A Startup in Bengaluru that uses artificial intelligence to detect breast cancer at an early stage has raised 6 million as funding. We all are aware that Breast Cancer is one of the most common cancers in India and thus does have a potential for huge business as well has social impact. The funds are needed for the organization to get the regulatory approvals, hire talent and expand in India primarily. The technology used by the startup is the key to early detection of the disease because there already is a shortage of skilled professionals and the breast ratio is too high too. The Japan based startup that has funded this Indian startup is also going to help the company expand internationally in Japan.
Though the startup was launched in 2016, with an objective of using AI to replace the present methods of mammography, which is an expensive equipped and a must for radiographers. The solution they offer is known as thermal-tix which is not only non-touch, but radiation free and non-painful imaging method.
As per the representative of the company, Nirmai as of now is the only company in the world that uses AI based thermal image processing as well as machine learning algorithms for reliable and trust worthy breast cancer screening. It is in the process of deploying its solution across 21 hospitals in 9 different cities. The representative also mentioned that the solution is an innovation and hence the implementation of it does require time. The organization is looking to touch-base rural areas besides metros, I and II tier cities.
One of the recognitions that already is in the kitty of this Bengaluru based startup is that it is the only Indian startup to be showcased under the CB (global business data intelligence platform) Insights 3rd annual list of 100 most promising startups across the world.
VIMS is one of the best cancer hospital in india, with 300 beds exclusively for cancer patients.Oncology department in the hospital has got qialified and well experienced doctors